Clinical Trial Update: Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Omacor co-administered with atorvastatin in hypertriglyceridemia completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Omacor (omega-3-acid ethyl esters)
• atorvastatin (atorvastatin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertriglyceridemia | Phase 3 | Status: COMPLETED | Results posted: 2009-05-12